𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb–IIIa inhibitors

✍ Scribed by Gen-Min Lin; Kai-Min Chu; Chih-Lu Han


Book ID
116549640
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
73 KB
Volume
146
Category
Article
ISSN
0167-5273

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES